Apolipoprotein E4 allele and ribosomal genes in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 6, Issue 4, 2004, Pages 391-395

  Tavares, Wagner Malagó ^a   Sperança, Marcia Aparecida ^a   De Labio, Roger Willian ^a   Peres, Clovis A ^b   Okamoto, Ivan Hideyo ^b   Bertolucci, Paulo Henrique Ferreira ^b   Smith, Marília De A C ^b   Payão, Spencer Luiz Marques ^a,b,c  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hemocentro   (Brazil)

Author keywords

28S 18SrRNA; Ageing; Alzheimer's disease; Apolipoprotein E; Ribosomal genes

Indexed keywords

APOLIPOPROTEIN E4; RIBOSOME RNA; RNA 18S; RNA 28S;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MALE; NERVE CELL; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOSOME; RISK FACTOR; RNA TRANSLATION; SLOT BLOT HYBRIDIZATION;

EID: 4644342295     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6406     Document Type: Article

References (38)

1. D. Allen and M.D. Roses, Apolipoprotein E alleles as risk factors in Alzheimer's disease, Annu. Rev. Med. 47 (1996), 387-400.
2. U. Beffert, M. Danik, P. Krzykowski, C. Ramassamy, F. Berrada and J. Poirier, The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease, Brain. Res. Rev. 27 (1998), 119-142.
3. B. Borsatto and M.A.C. Smith, Reduction of the activity of ribosomal genes with age in Down's syndrome, Gerontology 42 (1996), 147-154.
4. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell and G.W. Small et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
5. A.P. Feinberg and B. Volgestein, A technique of radiolabeling DNA restriction endonuclease fragments to high specific activity, Addendun Anal, Biochem 137 (1983), 266-267.
6. M.D. Gray, L. Wang, H. Youssoufian, G.M. Martin and J. Oshima, Werner helicase is localized to transcriptionally active nucleoli of cycling cells, Exp. Cell. Res. 242 (1998), 487-494.
7. K.H. Gylys, J.A. Fein, A.M. Tan and G.M. Cole, Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals, J. Neurochem. 84(6) (2003), 1442-1451.
8. Y. Hashimoto, H. Jiang, T. Niikura, Y. Ito, A. Hagiwara and K. Umezawa et al., Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases, J. Neurosci. 15 (2000), 8401-8409.
9. J.E. Hixson and D.T. Vernier, Restricion isotyping of human apolipoprotein e by gene amplification and cleavage with HhaI, J. Lipid. Res. 31 (1990), 545-548.
10. G. Houge, B. Robaye, T.S. Eikhom, J. Gostein, G. Mellgren and B.T. Gjertsen et al., Fine Mapping of 28S rRNA Sites Specifically Cleaved in Cells Undergoing Apoptosis, Mol. Cell Biol. 15 (1995), 2051-2062.
11. H.R. Hubbell, Silver staining as an indicator of active ribosomal genes, Stain Technol. 60 (1985), 285.
12. K. Iqbal, S.S. Sisodia and B. Winblad, Alzheimer's disease: advances in etiology, pathogenesis and therapeutics, Ohn Wiley & Sons, 2001, New York.
13. A. Koudinov and N. Koudinov, Brain cholesterol pathology is the cause of Alzheimer's disease, Clin. Med. Health. Res. (2001), clinmed/2001100005v1.
14. A.R. Koudinov, T.T. Berezov and N.V. Koudinova, Cholesterol and Alzheimer's disease: is there a link? Neurology 58 (2002), 1135.
15. R.W. Mahley, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science 40 (1988), 622-628.
16. F.S. McCallum and B.E.H. Maden, Human ribosomal RNA sequence inferred from DNA sequence, Biochem. J. 232 (1985), 725-733.
17. H.J. Menzel, R.G. Kladetzky and G. Assmann, Apolipoprotein E polymorphism and coronary artery disease, Arteriosclerosis 3 (1983), 310-315.
18. N. Mori, D. Mizuno and S. Goto, Increase in the ratio of 18S RNA to 28S RNA in the cytoplasm of mouse tissues during aging, Mech. Ageing Dev. 8(4) (1978), 285-297.
19. M. Michikawa, The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol, Mol. Neurobiol. 27(1) (2003), 1-12.
20. A.C. Mínguez and R.F. Cowburn, Apolipoprotein e: a major piece in the Alzheimer's disease puzzle, J. Cell. Mol. Med. 5 (2001), 254-266.
21. J.C. Morris, The Clinical Dementia Rating (CDR): current versation and scoring rules, Neurology 43 (1993), 2412-2414.
22. K.L. Moulder, M. Narita, L.K. Chang, G. Bu and E.M. Jr. Johnson, Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide, J. Neurochem. 72 (1999), 1069-1080.
23. D. Nadano and T.A. Sato, Caspase-3-dependent and independent degradation of 28S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement, J. Biol. Chem. 275 (2002), 13967-13973.
24. S. Nakagima-Ijima, H. Hamada, P. Reddy and T. Kakunaga, Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns, Proc. Natl. Acad. Sci. USA 82 (1985), 6133-3137.
25. J. Neter, M.H. Kutner, C.J. Nachtsheim and W. Wasserman, Applied linear statistical models, (4th ed.), Irwin, Boston, 1996, 1408.
26. S.L.M. Payão, M.A.C. Smith, M.H. Kormann-Bortolotto and J. Toniolo, Investigation of the Nucleolar Organizer Regions in Alzheimer's Disease, Gerontology 40 (1994), 13-17.
27. S.L.M. Payão, M.A.C. Smith, L.M.F. Winter and P.H.F. Bertolucci, Ribosomal RNA in Alzheimer's disease and Ageing, Mech. Ageing Dev. 105 (1998), 265-272.
28. M.A. Pericak-Vance, J.L. Bebout, P.C. Gaskall, L.H. Yamaoka, W.Y. Hung and M.J. Alberts et al., Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage, Am. J. Hum. Genet. 48 (1991), 1034-1050.
29. H. Rosenmann, Z. Meiner, E. Kahana, Z. Aladjem, G. Friedman and A. Bem-Yehuda et al., An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer's disease, Neurosci. Lett. 340(1) (2003), 29-32.
30. B.M. Ross, J.T. Knowler and J. McCulloch, On the stability of messenger RNA and ribosoma RNA in the brains of controls human subjects and patients with Alzheimer's disease, J. Neurochem. 58 (1992), 1810-1819.
31. D.C. Rubinsztein and D.F. Easton, Apolipoprotein E genetic variation and Alzheimer's disease. A metanalysis Dement, Geriatr. Cogn. Disord. 10 (1999), 199-209.
32. K. Sambamurti, N.H. Greig and K.L. Debomoy, Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer's Disease, Neuro Molecular Medicine 1 (2002), 1-31.
33. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance and S.H. Joo et al, Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993), 1467-1472.
34. D.J. Selkoe, Alzheimer's Disease: Genes, Proteins and Therapy, Phys. Ver. 81 (2001), 741-766.
35. A.M.A. Silva, S.L.M. Payão, B. Borsatto, P.H.F. Bertolucci and M.A.C. Smith, Quantitative evaluation of rRNA in Alzheimer's disease, Mech. Ageing Dev. 120 (2000), 57-64.
36. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses, Apolipoprotein E: high avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease, Proc. Natl. Acad. Sci. USA 90 (1993), 1977-1981.
37. S.R.B. Uliana, M.H.T. Alonso, E.P. Camargo and L.M. Floeter-Winter, Leishmania: genus identification based on a specific sequence of the 18S ribosomal RNA sequence, Exp. Parasitol. 72 (1991), 157-163.
38. C.E. Yu, J. Oshima, E.M. Wijsman, J. Nakura, T. Miki and C. Piussan et al., Mutations in the consensus helicase domains of the Werner syndrome gene, Am. J. Hum. Genet. 60 (1997), 330-341.